drugset
drugset / Trial / NCT03593707

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

NCT03593707 ↗

Phase 1 Completed 18 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

This study is designed to assess the effect of PF-06865571 administration on the pharmacokinetics of metformin in healthy adult subjects.

Timeline

Start
2018-08-17
Primary completion
2019-01-17
Completion
2019-02-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — —
Subject PF-06865571 Small molecule — —

Indications

No indication recorded.